Metabotropic glutamate receptor-5 modulators
CA 2468067 A1 · Owner: Vernier, Jean-Michel · Inventors: Wang, Bowei; Vernier, Jean-Michel; Bonnefous, Celine
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Phenyl compounds substituted at the 1-position with a fused bicyclo moeity formed from a five-membered heterocycle fused to a six-membered carbocycle to , a six-membered aryl, or to a six-membered hetaryl and further optionally , substituted at the 3,4 positions are mGluR5 modulators useful in the , treatment of psychiatric and mood disorders such as for example, schizophrenia, anxiety, depression and panic, as well as in the treatment of pain and other diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 26, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 26, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 26, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.